About Domainex

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally. Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years.

Domainex’s highly experienced molecular, protein, structural and assay biologists plus medicinal, computational and analytical chemists can be leveraged through our CRO services. Domainex’s focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets.

Domainex offers a range of services including:
• Medicinal chemistry (including SBDD)
• FragmentBuilder (Domainex’s proprietary fragment screening platform)
• Computational Chemistry (including LeadBuilder Domainex’s proprietary virtual screening platform)
• Assay Development and Screening (biochemical, biophysical and cell assays)
• iPSC and immune cell biology
• Protein Production
• CDH (Domainex’s proprietary technology which enables the rapid identification of stable, soluble protein domains)
• Analytical chemistry
• X-ray crystallography services

Whether your project is at an early stage of drug discovery or has already identified chemical matter, our processes have been shown to result in a 30% time-saving compared to industry standards and use less resource, allowing prudent management of your own budget.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Headquarter
Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, GB
description icon
Founded
2002
description icon
Keywords
Molecular Biology, Drug Discovery, Oncology, Biochemistry, Biophysics, Cell Biology, Analytical Chemistry, Inflammatory Diseases, Computational Chemistry, Kinase Inhibitor Research, Medicinal Chemistry, Virtual Screening, Gpcrs, Protein Production, X-Ray Crystallography, Fragment Screening, Cryo-Em, Protein-Protein Interactions, Assay Biology, Protease Inhibitor Research

Domainex Alternatives

Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about Domainex

Who is the CEO of Domainex?

Keith Powell is the CEO of Domainex. Or you may call 12017532055

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more